Springworks Therapeutics Stock Story
| SWTX Stock | USD 42.51 0.24 0.56% |
Slightly above 73% of SpringWorks Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding SpringWorks Therapeutics suggests that many traders are alarmed. SpringWorks Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in SpringWorks Therapeutics. The current market sentiment, together with SpringWorks Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use SpringWorks Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
SpringWorks Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SpringWorks daily returns and investor perception about the current price of SpringWorks Therapeutics as well as its diversification or hedging effects on your existing portfolios.
SpringWorks |
Requested story not found. it has been either deleted or moved. View all stories for SpringWorks Therapeutics.
SpringWorks Therapeutics Latest Timeline
SpringWorks Therapeutics is listed for 42.51. About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.15. SpringWorks Therapeutics had not issued any dividends in recent years.Check out SpringWorks Therapeutics Hype Analysis, SpringWorks Therapeutics Correlation and SpringWorks Therapeutics Performance. For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for SpringWorks Stock analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is SpringWorks Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.086 | Return On Assets (0.32) | Return On Equity (0.55) |
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.